247 related articles for article (PubMed ID: 37733442)
1. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer.
Kitamura F; Semba T; Yasuda-Yoshihara N; Yamada K; Nishimura A; Yamasaki J; Nagano O; Yasuda T; Yonemura A; Tong Y; Wang H; Akiyama T; Matsumura K; Uemura N; Itoyama R; Bu L; Fu L; Hu X; Wei F; Mima K; Imai K; Hayashi H; Yamashita YI; Miyamoto Y; Baba H; Ishimoto T
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37733442
[TBL] [Abstract][Full Text] [Related]
2. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
3. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
[TBL] [Abstract][Full Text] [Related]
4. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma.
Chen M; Cen K; Song Y; Zhang X; Liou YC; Liu P; Huang J; Ruan J; He J; Ye W; Wang T; Huang X; Yang J; Jia Y; Liang X; Shen P; Wang Q; Liang T
Cancer Lett; 2023 Jul; 567():216285. PubMed ID: 37354982
[TBL] [Abstract][Full Text] [Related]
5. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
Stouten I; van Montfoort N; Hawinkels LJAC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
[TBL] [Abstract][Full Text] [Related]
6. NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma.
Zhang P; Wang Q; Lu W; Zhang F; Wu D; Sun J
Sci Rep; 2024 Mar; 14(1):6979. PubMed ID: 38521881
[TBL] [Abstract][Full Text] [Related]
7. Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect.
Hu X; Peng X; Zhang Y; Fan S; Liu X; Song Y; Ren S; Chen L; Chen Y; Wang R; Peng J; Shen X; Chen Y
Phytomedicine; 2024 Jan; 123():155214. PubMed ID: 38134861
[TBL] [Abstract][Full Text] [Related]
8. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment.
Garcia Garcia CJ; Huang Y; Fuentes NR; Turner MC; Monberg ME; Lin D; Nguyen ND; Fujimoto TN; Zhao J; Lee JJ; Bernard V; Yu M; Delahoussaye AM; Jimenez Sacarello I; Caggiano EG; Phan JL; Deorukhkar A; Molkentine JM; Saur D; Maitra A; Taniguchi CM
Gastroenterology; 2022 Jun; 162(7):2018-2031. PubMed ID: 35216965
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer.
Zhu Y; Fang S; Fan B; Xu K; Xu L; Wang L; Zhu L; Chen C; Wu R; Ni J; Wang J
Theranostics; 2024; 14(4):1683-1700. PubMed ID: 38389839
[No Abstract] [Full Text] [Related]
11. CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy.
Yamashita K; Kumamoto Y
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892190
[TBL] [Abstract][Full Text] [Related]
12. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in the Tumor Microenvironment Mediated by Exosomal MicroRNAs.
Chu X; Yang Y; Tian X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076911
[TBL] [Abstract][Full Text] [Related]
14. Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment.
Nihashi Y; Song X; Yamamoto M; Setoyama D; Kida YS
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446193
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
[TBL] [Abstract][Full Text] [Related]
16. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
17. ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer.
Li YX; Zhu XX; Wu X; Li JH; Ni XH; Li SJ; Zhao W; Yin XY
Cancer Lett; 2022 Sep; 544():215802. PubMed ID: 35732215
[TBL] [Abstract][Full Text] [Related]
18. Neuromedin U regulates the anti-tumor activity of CD8
Zheng R; Wang S; Wang J; Zhou M; Shi Q; Liu B
Cancer Sci; 2024 Feb; 115(2):334-346. PubMed ID: 38071753
[TBL] [Abstract][Full Text] [Related]
19. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
